United States Compounding Pharmacy Market Report 2018

payment-methods
Secure Payment Methods

The Compounding Pharmacy market research report from Marketresearchpro consolidates the most important industry information while highlighting essential and valuable data regarding the status quo and trajectory of the Compounding Pharmacy industry with forecasts through next 5 years.

A management summary, key facts & figures, SWOT analysis and chief executive quotes on the latest developments in Compounding Pharmacy industry provide a substantial introduction. The report additionally provides quantitative information regarding Compounding Pharmacy industry financial numbers, selected key players and company details, as well as employee and salary data.

In the coming years, Compounding Pharmacy market will continue to focus their efforts on product innovation in order to attract new consumers and keep existing consumers loyal to specific brands.

Below is the majority of the content covered in this report

  • Compounding Pharmacy Product details, including pictures and technical specifications
  • Compounding Pharmacy manufacturers, distributors and channels
  • Major players present in the Compounding Pharmacy
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

This report covers a strategic profiling of the following key players in the Compounding Pharmacy market

  • Fagron
  • Wedgewood Pharma
  • CAPS
  • Fresenius Kabi
  • PharMEDium Services
  • Cantrell Drug
  • Advanced Pharma
  • Dougherty’s Pharmacy
  • Institutional Pharmacy Solutions
  • Lorraine’s Pharmacy
  • Village Compounding Pharmacy
  • Triangle Compounding Pharmacy
  • Olympia Pharmacy

The report covers the information pertaining to following geographies

  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest

Additionally, the market is segmented by the following sectors

  • Pharmaceutical ingredient alteration (PIA)
  • Pharmaceutical application alteration (PAA)
  • Currently unavailable pharmaceutical manufacturing (CUPM)
  • Pharmaceutical dosage alteration (PDA)
  • Specialized animal pharmaceutical manufacturing (SAPM)

Please contact us if you are looking for any other possible breakdown across the products.

Not only this, figures covering the end user applications are also provided according to the following classification

  • Consumers aged 18 and younger
  • Consumers aged 19 to 44
  • Consumers aged 45 to 64
  • Consumers aged 65 and older

In summary, the report serves to study and analyse the Compounding Pharmacy size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Compounding Pharmacy, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • United States Compounding Pharmacy Market Report 2018
  • 1 Compounding Pharmacy Overview
    • 1.1 Product Overview and Scope of Compounding Pharmacy
    • 1.2 Classification of Compounding Pharmacy by Product Category
      • 1.2.1 United States Compounding Pharmacy Market Size (Sales Volume) Comparison by Type (2013-2025)
      • 1.2.2 United States Compounding Pharmacy Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
      • 1.2.3 Pharmaceutical ingredient alteration (PIA)
      • 1.2.4 Pharmaceutical application alteration (PAA)
      • 1.2.5 Currently unavailable pharmaceutical manufacturing (CUPM)
      • 1.2.6 Pharmaceutical dosage alteration (PDA)
      • 1.2.7 Specialized animal pharmaceutical manufacturing (SAPM)
    • 1.3 United States Compounding Pharmacy Market by Application/End Users
      • 1.3.1 United States Compounding Pharmacy Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
      • 1.3.2 Consumers aged 18 and younger
      • 1.3.3 Consumers aged 19 to 44
      • 1.3.4 Consumers aged 45 to 64
      • 1.3.5 Consumers aged 65 and older
    • 1.4 United States Compounding Pharmacy Market by Region
      • 1.4.1 United States Compounding Pharmacy Market Size (Value) Comparison by Region (2013-2025)
      • 1.4.2 The West Compounding Pharmacy Status and Prospect (2013-2025)
      • 1.4.3 Southwest Compounding Pharmacy Status and Prospect (2013-2025)
      • 1.4.4 The Middle Atlantic Compounding Pharmacy Status and Prospect (2013-2025)
      • 1.4.5 New England Compounding Pharmacy Status and Prospect (2013-2025)
      • 1.4.6 The South Compounding Pharmacy Status and Prospect (2013-2025)
      • 1.4.7 The Midwest Compounding Pharmacy Status and Prospect (2013-2025)
    • 1.5 United States Market Size (Value and Volume) of Compounding Pharmacy (2013-2025)
      • 1.5.1 United States Compounding Pharmacy Sales and Growth Rate (2013-2025)
      • 1.5.2 United States Compounding Pharmacy Revenue and Growth Rate (2013-2025)
  • 2 United States Compounding Pharmacy Market Competition by Players/Suppliers
    • 2.1 United States Compounding Pharmacy Sales and Market Share of Key Players/Suppliers (2013-2018)
    • 2.2 United States Compounding Pharmacy Revenue and Share by Players/Suppliers (2013-2018)
    • 2.3 United States Compounding Pharmacy Average Price by Players/Suppliers (2013-2018)
    • 2.4 United States Compounding Pharmacy Market Competitive Situation and Trends
      • 2.4.1 United States Compounding Pharmacy Market Concentration Rate
      • 2.4.2 United States Compounding Pharmacy Market Share of Top 3 and Top 5 Players/Suppliers
      • 2.4.3 Mergers & Acquisitions, Expansion in United States Market
    • 2.5 United States Players/Suppliers Compounding Pharmacy Manufacturing Base Distribution, Sales Area, Product Type
  • 3 United States Compounding Pharmacy Sales (Volume) and Revenue (Value) by Region (2013-2018)
    • 3.1 United States Compounding Pharmacy Sales and Market Share by Region (2013-2018)
    • 3.2 United States Compounding Pharmacy Revenue and Market Share by Region (2013-2018)
    • 3.3 United States Compounding Pharmacy Price by Region (2013-2018)
  • 4 United States Compounding Pharmacy Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
    • 4.1 United States Compounding Pharmacy Sales and Market Share by Type (Product Category) (2013-2018)
    • 4.2 United States Compounding Pharmacy Revenue and Market Share by Type (2013-2018)
    • 4.3 United States Compounding Pharmacy Price by Type (2013-2018)
    • 4.4 United States Compounding Pharmacy Sales Growth Rate by Type (2013-2018)
  • 5 United States Compounding Pharmacy Sales (Volume) by Application (2013-2018)
    • 5.1 United States Compounding Pharmacy Sales and Market Share by Application (2013-2018)
    • 5.2 United States Compounding Pharmacy Sales Growth Rate by Application (2013-2018)
    • 5.3 Market Drivers and Opportunities
  • 6 United States Compounding Pharmacy Players/Suppliers Profiles and Sales Data
    • 6.1 Fagron
      • 6.1.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.1.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.1.2.1 Product A
        • 6.1.2.2 Product B
      • 6.1.3 Fagron Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.1.4 Main Business/Business Overview
    • 6.2 Wedgewood Pharma
      • 6.2.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.2.2.1 Product A
        • 6.2.2.2 Product B
      • 6.2.3 Wedgewood Pharma Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.2.4 Main Business/Business Overview
    • 6.3 CAPS
      • 6.3.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.3.2.1 Product A
        • 6.3.2.2 Product B
      • 6.3.3 CAPS Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.3.4 Main Business/Business Overview
    • 6.4 Fresenius Kabi
      • 6.4.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.4.2.1 Product A
        • 6.4.2.2 Product B
      • 6.4.3 Fresenius Kabi Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.4.4 Main Business/Business Overview
    • 6.5 PharMEDium Services
      • 6.5.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.5.2.1 Product A
        • 6.5.2.2 Product B
      • 6.5.3 PharMEDium Services Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.5.4 Main Business/Business Overview
    • 6.6 Cantrell Drug
      • 6.6.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.6.2.1 Product A
        • 6.6.2.2 Product B
      • 6.6.3 Cantrell Drug Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.6.4 Main Business/Business Overview
    • 6.7 Advanced Pharma
      • 6.7.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.7.2.1 Product A
        • 6.7.2.2 Product B
      • 6.7.3 Advanced Pharma Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.7.4 Main Business/Business Overview
    • 6.8 Dougherty’s Pharmacy
      • 6.8.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.8.2.1 Product A
        • 6.8.2.2 Product B
      • 6.8.3 Dougherty’s Pharmacy Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.8.4 Main Business/Business Overview
    • 6.9 Institutional Pharmacy Solutions
      • 6.9.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.9.2.1 Product A
        • 6.9.2.2 Product B
      • 6.9.3 Institutional Pharmacy Solutions Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.9.4 Main Business/Business Overview
    • 6.10 Lorraine’s Pharmacy
      • 6.10.2 Compounding Pharmacy Product Category, Application and Specification
        • 6.10.2.1 Product A
        • 6.10.2.2 Product B
      • 6.10.3 Lorraine’s Pharmacy Compounding Pharmacy Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.10.4 Main Business/Business Overview
    • 6.11 Village Compounding Pharmacy
    • 6.12 Triangle Compounding Pharmacy
    • 6.13 Olympia Pharmacy
  • 7 Compounding Pharmacy Manufacturing Cost Analysis
    • 7.1 Compounding Pharmacy Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Price Trend of Key Raw Materials
      • 7.1.3 Key Suppliers of Raw Materials
      • 7.1.4 Market Concentration Rate of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
      • 7.2.1 Raw Materials
      • 7.2.2 Labor Cost
      • 7.2.3 Manufacturing Expenses
    • 7.3 Manufacturing Process Analysis of Compounding Pharmacy
  • 8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    • 8.1 Compounding Pharmacy Industrial Chain Analysis
    • 8.2 Upstream Raw Materials Sourcing
    • 8.3 Raw Materials Sources of Compounding Pharmacy Major Manufacturers in 2017
    • 8.4 Downstream Buyers
  • 9 Marketing Strategy Analysis, Distributors/Traders
    • 9.1 Marketing Channel
      • 9.1.1 Direct Marketing
      • 9.1.2 Indirect Marketing
      • 9.1.3 Marketing Channel Development Trend
    • 9.2 Market Positioning
      • 9.2.1 Pricing Strategy
      • 9.2.2 Brand Strategy
      • 9.2.3 Target Client
    • 9.3 Distributors/Traders List
  • 10 Market Effect Factors Analysis
    • 10.1 Technology Progress/Risk
      • 10.1.1 Substitutes Threat
      • 10.1.2 Technology Progress in Related Industry
    • 10.2 Consumer Needs/Customer Preference Change
    • 10.3 Economic/Political Environmental Change
  • 11 United States Compounding Pharmacy Market Size (Value and Volume) Forecast (2018-2025)
    • 11.1 United States Compounding Pharmacy Sales Volume, Revenue Forecast (2018-2025)
    • 11.2 United States Compounding Pharmacy Sales Volume Forecast by Type (2018-2025)
    • 11.3 United States Compounding Pharmacy Sales Volume Forecast by Application (2018-2025)
    • 11.4 United States Compounding Pharmacy Sales Volume Forecast by Region (2018-2025)
  • 12 Research Findings and Conclusion
  • 13 Appendix
    • 13.1 Methodology/Research Approach
      • 13.1.1 Research Programs/Design
      • 13.1.2 Market Size Estimation
      • 13.1.3 Market Breakdown and Data Triangulation
    • 13.2 Data Source
      • 13.2.1 Secondary Sources
      • 13.2.2 Primary Sources
    • 13.3 Disclaimer

Request a FREE Sample


PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Our Happy Customers

Request a FREE Sample